Seres amends Cambridge lease: surrenders 14,760 sq ft, extends 68,636 sq ft to Jan 2030

Seres Therapeutics, Inc.

Surrenders 14,760 rentable sq ft of office/lab space effective Nov 12, 2023.
Extends lease on remaining 68,636 sq ft to Jan 13, 2030; initial rent $122/sq ft/yr with 3% annual escalations.
Receives 2-month free rent at start of extension and $1.72M tenant improvement allowance ($25/sq ft).
Rentable area after surrender: 68,636 sq ft; tenant's pro rata share in building becomes 36.39%.

item 1.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Seres Therapeutics, Inc. amended First Amendment to Lease with BMR-Sidney Research Campus LLC (effective 2022-12-09).

Action: amendment
Agreement: lease
Counterparty: BMR-Sidney Research Campus LLC
Effective: 2022-12-09

Exact text from the filing

On December 9, 2022, Seres Therapeutics, Inc. (the “Company”) entered into the First Amendment to Lease (the “First Amendment”) with BMR-Sidney Research Campus LLC (f/k/a BMR 200-Sidney Street LLC), a Delaware limited liability company (the “Landlord”), which amends the Lease Agreement, dated November 11, 2015

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

Seres Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-304803

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.